: The combined use of a pressurized metered-dose inhaler and valved holding chamber (pMDI+VHC) is recommended to improve efficiency and safety; however, aerosol release is likely to vary with the inhalation maneuver. This study investigated the aerodynamic characteristics and aerosol release features of pMDI+VHC (Aerochamber, Trudell Medical International). : The static and dynamic changes in the airway resistance () during inhalation (withdrawal) through pMDI+VHC were measured. Subsequently, the aerosol released from pMDI+VHC was measured using simplified laser photometry during withdrawal with either fast ramp-up then steady or slow ramp-up followed by gradual decrement at different intensities and times to peak flow (). increased linearly with changes in the withdrawal flow (WF) rate between 10 and 50 L/min. The slope was steep in the low WF range (<50 L/min) and became milder in the higher range. The aerosol mass tended to increase with an increase in the peak WF (PWF) of slow ramp-up profile. When three different WF increment slopes (: 0.4, 1.4, and 2.4 seconds) were compared, the released aerosol mass tended to decrease, and the aerosol release time was prolonged at longer . When the PWF was increased, the aerosol release time became shorter, and the withdrawn volume required for 95% aerosol release became larger; however, it did not exceed 0.4 L at suitable (0.4 seconds). : analysis suggests that inhalation at 30-50 L/min is suitable for pMDI+VHC in this setting. Rapid (, 0.4 seconds) inhalation, but not necessarily long (maximum 2.0 seconds) and deep (but larger than 0.55 L), is also recommended. Practically, direct inhalation to be weaker than usual breathing, as fast as possible, and far less than 2.0 seconds.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/jamp.2023.0019 | DOI Listing |
Prehosp Emerg Care
December 2024
Department of Emergency Medicine, College of Medicine, The University of Arizona, Tucson, AZ.
Objectives: Hydrazine (HZ) and Hydrazine Derivative (HZ-D) exposures pose health risks to people in industrial and aerospace settings. Several recent systematic reviews and case series have highlighted common clinical presentations and management strategies. Given the low frequency at which HZ and HZ-D exposures occur, a strong evidence base on which to develop an evidence-based guideline does not exist at this time.
View Article and Find Full Text PDFVet Anaesth Analg
October 2024
Small Animal Hospital, University of Glasgow, School of Biodiversity, One Health and Veterinary Medicine, Glasgow, UK.
Objective: To investigate which breathing systems are available and why they are selected in dogs weighing 5-10 kg.
Study Design: Anonymous online voluntary open survey.
Methods: An online survey, designed following CHERRIES guidelines, was advertised through the American College of Veterinary Anesthesiologists - List, Association of Veterinary Anaesthesia and European College of Veterinary Anaesthesia and Analgesia (February-March 2022).
J Asthma
December 2024
Pharmacy Department, Institut Perubatan Respiratori, Ministry of Health Malaysia, Jalan Pahang, Kuala Lumpur, Malaysia.
Background: The Global Initiative for Asthma (GINA) has suggested the need for more studies on inhaled corticosteroid (ICS)-formoterol in the Emergency Department (ED).
Objectives: We aimed to compare the outcomes of budesonide/formoterol (160/4.5 mcg/inhalation) turbuhaler versus pressurized metered-dose inhaler (pMDI) salbutamol (100 mcg/puff) in acute asthma in the outpatient ED.
Respir Care
October 2024
Mss Fonzie and Willis are affiliated with Respiratory Care Services, Arkansas Children's Hospital, Little Rock, Arkansas.
Clin Cardiol
November 2024
Department of Internal Medicine, Istanbul University, Faculty of Medicine, Istanbul, Turkey.
Background: Volatile substance (thinner) addiction can cause serious cardiac events, such as malignant ventricular arrhythmias, acute coronary syndromes, sudden death syndrome, and dilated cardiomyopathy, as reported in many case studies. We aimed to find echocardiographic and electrocardiographic parameters that could foresee these adverse outcomes in clinical settings.
Methods: We enrolled 32 healthy young adult patients with at least 1 year of thinner addiction and no cardiac symptoms.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!